Abstract
Human enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) are major causative agents of hand, foot, and mouth disease (HFMD) especially in infants and children under 5 years of age. Despite recent outbreaks of HFMD, there are no approved therapeutics against EV71 and CA16 infection. Moreover, in a small percentage of cases, the disease progression can lead to serious complications of the central nervous system. In this study, we investigated the antiviral effect of corilagin and Phyllanthus urinaria extract, which contains corilagin as a major component, on EV71 and CA16 infection in vitro. Our results indicate that corilagin reduces the cytotoxicity induced by EV71 or CA16 on Vero cells with and IC50 value of 5.6 and 32.33 μg/mL, respectively. We confirmed the presence of corilagin in EtOAc and BuOH fractions from P. urinaria extract and this correlated with antiviral activity of the fractions against EV71 or CA16. Future studies will be required to confirm the antiviral activity of corilagin and P. urinaria extract in vivo. Challenging a model with a lethal dose of viral infection will be required to test this. Collectively, our work provides potential candidates for the development of novel drugs to treat HFMD.
Similar content being viewed by others
References
Chen, Y., and C. Chen. 2011. Corilagin prevents tert-butyl hydroperoxide-induced oxidative stress injury in cultured n9 murine microglia cells. Neurochemistry International 59(2): 290–296.
Cheng, A., C.P. Fung, C.C. Liu, Y.T. Lin, H.Y. Tsai, S.C. Chang, A.H. Chou, J.Y. Chang, R.H. Jiang, Y.C. Hsieh, I.J. Su, et al. 2013. A phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 31(20): 2471–2476.
Choi, H.J., J.H. Kim, C.H. Lee, Y.J. Ahn, J.H. Song, S.H. Baek, and D.H. Kwon. 2009a. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Research 81(1): 77–81.
Choi, H.J., J.H. Song, K.S. Park, and D.H. Kwon. 2009b. Inhibitory effects of quercetin 3-rhamnoside on influenza a virus replication. European Journal of Pharmaceutical Sciences 37(3–4): 329–333.
Duan, W., Y. Yu, and L. Zhang. 2005. Antiatherogenic effects of Phyllanthus emblica associated with corilagin and its analogue. Yakugaku Zasshi 125(7): 587–591.
Guo, Y.J., L. Zhao, X.F. Li, Y.W. Mei, S.L. Zhang, J.Y. Tao, Y. Zhou, and J.H. Dong. 2010. Effect of corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias. European Journal of Pharmacology 635(1–3): 79–86.
Hau, D.K., G.Y. Zhu, A.K. Leung, R.S. Wong, G.Y. Cheng, P.B. Lai, S.W. Tong, F.Y. Lau, K.W. Chan, W.Y. Wong, K.H. Lam, et al. 2010. In vivo anti-tumour activity of corilagin on hep3b hepatocellular carcinoma. Phytomedicine 18(1): 11–15.
Jikai, L., H. Yue, T. Henkel, and K. Weber. 2002. One step purification of corilagin and ellagic acid from Phyllanthus urinaria using high-speed countercurrent chromatography. Phytochemical Analysis 13(1): 1–3.
Kinoshita, S., Y. Inoue, S. Nakama, T. Ichiba, and Y. Aniya. 2007. Antioxidant and hepatoprotective actions of medicinal herb, terminalia catappa L. From okinawa island and its tannin corilagin. Phytomedicine 14(11): 755–762.
Li, Y., S. Yu, D. Liu, P. Proksch, and W. Lin. 2012. Inhibitory effects of polyphenols toward HCV from the mangrove plant excoecaria agallocha L. Bioorganic Medicinal Chemistry Letters 22(2): 1099–1102.
Lin, S.Y., C.C. Wang, Y.L. Lu, W.C. Wu, and W.C. Hou. 2008. Antioxidant, anti-semicarbazide-sensitive amine oxidase, and anti-hypertensive activities of geraniin isolated from Phyllanthus urinaria. Food and Chemical Toxicology 46(7): 2485–2492.
Lin, L.T., T.Y. Chen, C.Y. Chung, R.S. Noyce, T.B. Grindley, C. McCormick, T.C. Lin, G.H. Wang, C.C. Lin, and C.D. Richardson. 2011. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. Journal of Virology 85(9): 4386–4398.
Lin, L.T., T.Y. Chen, S.C. Lin, C.Y. Chung, T.C. Lin, G.H. Wang, R. Anderson, C.C. Lin, and C.D. Richardson. 2013. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiology 13: 187.
Liu, K.C., M.T. Lin, S.S. Lee, J.F. Chiou, S. Ren, and E.J. Lien. 1999. Antiviral tannins from two phyllanthus species. Planta Medica 65(1): 43–46.
Mao, Q., Wang, Y., Yao, X., Bian, L., Wu, X., Xu, M., Liang, Z. 2013. Coxsackievirus a16: epidemiology, diagnosis, and vaccine. Human Vaccines Immunotherapeutics 10(2): 360–367.
Moreira, J., L.C. Klein-Junior, V. Cechinel Filho, and F. de Campos Buzzi. 2013. Anti-hyperalgesic activity of corilagin, a tannin isolated from Phyllanthus niruri L. (euphorbiaceae). Journal of Ethnopharmacology 146(1): 318–323.
Notka, F., G. Meier, and R. Wagner. 2004. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Research 64(2): 93–102.
Park, J.H., H.S. Joo, K.Y. Yoo, B.N. Shin, I.H. Kim, C.H. Lee, J.H. Choi, K. Byun, B. Lee, S.S. Lim, M.J. Kim, et al. 2011. Extract from terminalia chebula seeds protect against experimental ischemic neuronal damage via maintaining SODs and BDNF levels. Neurochemical Research 36(11): 2043–2050.
Patel, J.R., P. Tripathi, V. Sharma, N.S. Chauhan, and V.K. Dixit. 2011. Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. Journal of Ethnopharmacology 138(2): 286–313.
Satomi, H., K. Umemura, A. Ueno, T. Hatano, T. Okuda, and T. Noro. 1993. Carbonic anhydrase inhibitors from the pericarps of punica granatum L. Biological Pharmaceutical Bulletin 16(8): 787–790.
Shiota, S., M. Shimizu, J. Sugiyama, Y. Morita, T. Mizushima, and T. Tsuchiya. 2004. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant staphylococcus aureus. Microbiology and Immunology 48(1): 67–73.
Solomon, T., P. Lewthwaite, D. Perera, M.J. Cardosa, P. McMinn, and M.H. Ooi. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infectious Diseases 10(11): 778–790.
Tan, C.W., Y.F. Chan, K.M. Sim, E.L. Tan, and C.L. Poh. 2012. Inhibition of enterovirus 71 (ev-71) infections by a novel antiviral peptide derived from EV-71 capsid protein vp1. PLoS One 7(5): e34589.
Thitilertdecha, N., A. Teerawutgulrag, J.D. Kilburn, and N. Rakariyatham. 2010. Identification of major phenolic compounds from nephelium lappaceum 1. And their antioxidant activities. Molecules (Basel, Switzerland) 15(3): 1453–1465.
Yang, Y., J. Xiu, L. Zhang, C. Qin, and J. Liu. 2012a. Antiviral activity of punicalagin toward human enterovirus 71 in vitro and in vivo. Phytomedicine 20(1): 67–70.
Yang, Y., L. Zhang, X. Fan, C. Qin, and J. Liu. 2012b. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo. Bioorganic Medicinal Chemistry Letters 22(6): 2209–2211.
Yang, Y., J. Xiu, J. Liu, L. Zhang, X. Li, Y. Xu, and C. Qin. 2013. Chebulagic acid, a hydrolysable tannin, exhibited antiviral activity in vitro and in vivo against human enterovirus 71. International Journal of Molecular Sciences 14(5): 9618–9627.
Yuandani, M. Ilangkovan, I. Jantan, H.F. Mohamad, K. Husain, and A.F. Abdul Razak. 2013. Inhibitory effects of standardized extracts of Phyllanthus amarus and Phyllanthus urinaria and their marker compounds on phagocytic activity of human neutrophils. Evidence-Based Complementary and Alternative Medicine 2013: 603634. doi:10.1155/2013/603634
Zhao, L., S.L. Zhang, J.Y. Tao, R. Pang, F. Jin, Y.J. Guo, J.H. Dong, P. Ye, H.Y. Zhao, and G.H. Zheng. 2008. Preliminary exploration on anti-inflammatory mechanism of corilagin (beta-1-o-galloyl-3,6-(r)-hexahydroxydiphenoyl-d-glucose) in vitro. International Immunopharmacology 8(7): 1059–1064.
Zheng, Z., H. Li, Z. Zhang, J. Meng, D. Mao, B. Bai, B. Lu, P. Mao, Q. Hu, and H. Wang. 2011. Enterovirus 71 2c protein inhibits tnf-alpha-mediated activation of nf-kappab by suppressing ikappab kinase beta phosphorylation. Journal of immunology (Baltimore, Md : 1950) 187(5): 2202–2212.
Acknowledgments
This work was supported by a grant from R&D project (2013-NG48001-00) at Korea National Institute of Health. This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0009018).
Author information
Authors and Affiliations
Corresponding author
Additional information
Sang-Gu Yeo, Jae Hyoung Song, Jae-Hak Park, Hyun-Jeong Ko equally contributed to this paper.
Rights and permissions
About this article
Cite this article
Yeo, SG., Song, J.H., Hong, EH. et al. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro. Arch. Pharm. Res. 38, 193–202 (2015). https://doi.org/10.1007/s12272-014-0390-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-014-0390-9